FDA Approves Vivitrol For Opioid Addiction Rehab

Nearly 11 million teens and young adults in the U.S. are suffering from alcohol or drug related problems, according to The Partnership at Drugfree.org. The nonprofit organization is dedicated to assisting parents whose children are struggling with substance abuse. Individuals suffering from addiction, which is a chronic illness, can find the resources they need to recover at drug rehabilitation facilities across the country.

On October 12, the U.S. Food and Drug Administration (FDA) approved an opioid dependence medication called Vivitrol. The drug will give new treatment options to opioid addicts and is expected to bring relief to their families.

“Opioid dependence, whether from misuse of prescription pain medications or illicit use of heroin, is one of the most imperative health issues facing our nation,” said Steve Pasierb, president and chief executive officer of The Partnership at Drugfree.org.

Support groups, such as the Time to Get Help program developed by the nonprofit, are dedicated to providing families with the resources they need to find treatment for addiction. Almost 23 million Americans who are aged 12 or older deal with substance abuse, according to The Partnership at Drugfree.org. Substance abuse programs for youth can help addicts and their families recover and live healthier lives.